Healthcare systems designed around male physiology as default have created parallel blind spots for both women and men, undermining the personalization claims central to longevity medicine. Addressing sex-specific biology, diagnostic gaps, and equitable access is foundational to advancing longevity outcomes across populations.
Key Points
- Clinical frameworks exclude female biology, creating diagnostic and treatment gaps
- Male default model disadvantages men in preventive care and health conversations
- Personalized medicine cannot function without sex-disaggregated data and protocols
Longevity Analysis
The longevity field's emphasis on precision and personalization remains structurally incomplete when foundational protocols—dosing, biomarker ranges, risk assessment—were calibrated on male physiology alone. This affects how practitioners decode hormonal patterns, assess defense and stress response systems, and interpret metabolic signals across the lifespan. Until these reference points are rebuilt to account for sex-specific physiology, neither women nor men receive accurate guidance on prevention, early intervention, or optimization. Equity in longevity is not an ethical addendum; it is a clinical prerequisite. Systems cannot adapt to individual variation when the baseline itself is systematically skewed.
Original published by Longevity.Technology, by Eleanor Garth.